Evidence map›Paper›PMID 35100413›Full record

ArticleNucleic acids research2022

Cryo-EM structure of the ancient eukaryotic ribosome from the human parasite Giardia lamblia.

Disha-Gajanan Hiregange, Andre Rivalta, Tanaya Bose, Elinor Breiner-Goldstein, Sarit Samiya, Giuseppe Cimicata, Liudmila Kulakova, Ella Zimmerman, Anat Bashan, Osnat Herzberg and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. RiboScreenBiomedicines · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Exploration ofParasitology · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Disha-Gajanan HiregangeDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Andre RivaltaDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Tanaya BoseDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Elinor Breiner-GoldsteinDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Sarit SamiyaDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Giuseppe CimicataDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Liudmila KulakovaInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20742-4454, USA.
Ella ZimmermanDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Anat BashanDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0002-7705-0466
Osnat HerzbergInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20742-4454, USA.
Ada YonathDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Weizmann Institute of Science · ILAdvanced Bioscience Laboratories (United States) · US

Funding

Fumagillin Derivatives as Novel Antigiardiasis and Antiamebiasis DrugsR33AI119788 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI HERZBERG, OSNAT · 2017 to 2019
$1.3M
Fumagillin Derivatives as Novel Antigiardiasis and Antiamebiasis DrugsR21AI119788 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI HERZBERG, OSNAT · 2015 to 2016
$418k
NIAID NIH HHS R21 AI119788NIAID NIH HHS R33 AI119788
6 · The paper itself

Abstract

Giardiasis is a disease caused by the protist Giardia lamblia. As no human vaccines have been approved so far against it, and resistance to current drugs is spreading, new strategies for combating giardiasis need to be developed. The G. lamblia ribosome may provide a promising therapeutic target due to its distinct sequence differences from ribosomes of most eukaryotes and prokaryotes. Here, we report the cryo-electron microscopy structure of the G. lamblia (WB strain) ribosome determined at 2.75 Å resolution. The ribosomal RNA is the shortest known among eukaryotes, and lacks nearly all the eukaryote-specific ribosomal RNA expansion segments. In contrast, the ribosomal proteins are typically eukaryotic with some species-specific insertions/extensions. Most typical inter-subunit bridges are maintained except for one missing contact site. Unique structural features are located mainly at the ribosome's periphery. These may be exploited as target sites for the design of new compounds that inhibit selectively the parasite's ribosomal activity.

Indexed as

Giardia lambliaGiardiasisParasitesAnimalsCryoelectron MicroscopyEukaryotaHumansRibosomesRNA, RibosomalRNA, Ribosomal

Identifiers

PMID35100413
PMCPMC8860606
OpenAlexW4210494639

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.